NDC 62064-041

Egrifta

Tesamorelin

Egrifta is a Subcutaneous Kit in the Human Prescription Drug category. It is labeled and distributed by Theratechnologies Inc.. The primary component is .

• Product ID: 62064-041_a2509913-6b13-4c99-a0fe-b904078a2745
• NDC: 62064-041
• Product Type: Human Prescription Drug
• Proprietary Name: Egrifta
• Generic Name: Tesamorelin
• Dosage Form: Kit
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2019-07-01
• Marketing Category: NDA / NDA
• Application Number: NDA022505
• Labeler Name: Theratechnologies Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 62064-041-30

1 KIT in 1 BOX (62064-041-30) * .5 mL in 1 VIAL * 30 BOTTLE in 1 TRAY > 10 mL in 1 BOTTLE

• Marketing Start Date: 2019-07-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62064-041-30 [62064004130]

Egrifta KIT

• Marketing Category: NDA
• Application Number: NDA022505
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-07-01
• Marketing End Date: 2019-07-01

Drug Details

OpenFDA Data

• SPL SET ID: 57d892a0-1fe1-4f30-8ef1-0b57e8a2b786
• Manufacturer:
  • Theratechnologies Inc.
• RxNorm Concept Unique ID - RxCUI:
  • 1044591
  • 1044587

NDC Crossover Matching brand name "Egrifta" or generic name "Tesamorelin"

NDC	Brand Name	Generic Name
62064-011	Egrifta	tesamorelin
62064-041	Egrifta	tesamorelin
62064-241	EGRIFTA SV	tesamorelin